Bambusa Therapeutics Inc.
- Address
- 22 Boston Wharf Road Floor 7
Sponsor Overview
Specializations
Inflammatory Skin Disease
Bambusa Therapeutics Inc. is involved in clinical research for atopic dermatitis, with interest in therapies aimed at the underlying immune-driven features of chronic skin inflammation and symptom burden in adult patients.
- Atopic dermatitis
- Adult dermatology
- Immune-mediated skin inflammation
The sponsor’s research activity in this area reflects a focus on dermatologic conditions where persistent inflammation and skin barrier dysfunction are central therapeutic concerns.
Chronic Airway Disease
The company also supports clinical studies in chronic obstructive pulmonary disease, addressing respiratory disease domains associated with airflow limitation, chronic symptoms, and long-term pulmonary impairment.
- Chronic obstructive pulmonary disease
- Respiratory inflammation
- Airway obstruction
This area of interest places emphasis on therapies relevant to chronic respiratory care and disease control in adults with enduring lung disease.
Upper Airway Inflammatory Disorders
Bambusa Therapeutics Inc. is active in research on chronic rhinosinusitis with nasal polyps, a condition marked by persistent sinonasal inflammation and structural disease of the upper airway.
- Chronic rhinosinusitis with nasal polyps
- Nasal polyps
- Sinonasal inflammation
The sponsor’s clinical interest extends to inflammatory conditions affecting nasal and sinus function, where symptom persistence and tissue swelling are major treatment targets.
Comorbid Asthma
Its portfolio includes studies involving asthma in the setting of comorbid respiratory disease, highlighting interest in overlapping airway inflammation and combined disease burden.
- Asthma
- Comorbid respiratory disease
- Airway hyperreactivity
This therapeutic area reflects attention to patients with interconnected lower and upper airway conditions, where respiratory symptoms may coexist and influence clinical management.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 1 Randomized, Double‑Blind, Placebo‑Controlled Study of BBT001 in Healthy Volunteers and Adults with Atopic Dermatitis |  Poland | Not Yet Recruiting |
| A Phase I/II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of BBT002 in Healthy Volunteers and Patients with COPD, CRSwNP, or Comorbid Asthma | Poland | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 9 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
- 2.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
9 centres- Address
- Ul. Sokolowska 9/u2, 01-142 Nadarzyn
- Address
- Kwiatowa 1/1K, 85-047 Bydgoszcz
- Address
- Plac Szczepanski 3, 31-011 Krakow
- Address
- Ul. Ul. Sliczna 13, 50-566 Wroclaw
- Address
- Ul. Woloska 137, 02-507 Warsaw
- Address
- Ul. Unii Lubelskiej 1, 71-252 Szczecin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Bambusa Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.